BLAC_NOCAS
ID BLAC_NOCAS Reviewed; 310 AA.
AC Q9EZQ7;
DT 15-JAN-2008, integrated into UniProtKB/Swiss-Prot.
DT 01-MAR-2001, sequence version 1.
DT 03-AUG-2022, entry version 70.
DE RecName: Full=Beta-lactamase AST-1;
DE EC=3.5.2.6;
DE Flags: Precursor;
GN Name=bla; Synonyms=ast1;
OS Nocardia asteroides.
OC Bacteria; Actinobacteria; Corynebacteriales; Nocardiaceae; Nocardia.
OX NCBI_TaxID=1824;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], ACTIVITY REGULATION, AND
RP BIOPHYSICOCHEMICAL PROPERTIES.
RX PubMed=11181374; DOI=10.1128/aac.45.3.878-882.2001;
RA Poirel L., Laurent F., Naas T., Labia R., Boiron P., Nordmann P.;
RT "Molecular and biochemical analysis of AST-1, a class A beta-lactamase from
RT Nocardia asteroides sensu stricto.";
RL Antimicrob. Agents Chemother. 45:878-882(2001).
CC -!- FUNCTION: Confers high levels of resistance to amoxicillin,
CC benzylpenicillin, piperacillin, ticarcillin and cephalothin. Not active
CC against ceftazidime, cefotaxime and aztreonam.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=a beta-lactam + H2O = a substituted beta-amino acid;
CC Xref=Rhea:RHEA:20401, ChEBI:CHEBI:15377, ChEBI:CHEBI:35627,
CC ChEBI:CHEBI:140347; EC=3.5.2.6; Evidence={ECO:0000255|PROSITE-
CC ProRule:PRU10101};
CC -!- ACTIVITY REGULATION: Inhibited by clavulanic acid.
CC {ECO:0000269|PubMed:11181374}.
CC -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC Kinetic parameters:
CC KM=30 uM for benzylpenicillin {ECO:0000269|PubMed:11181374};
CC KM=50 uM for amoxicillin {ECO:0000269|PubMed:11181374};
CC KM=7 uM for ticarcillin {ECO:0000269|PubMed:11181374};
CC KM=330 uM for piperacillin {ECO:0000269|PubMed:11181374};
CC KM=20 uM for cephalothin {ECO:0000269|PubMed:11181374};
CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Lipid-anchor
CC {ECO:0000250}.
CC -!- SIMILARITY: Belongs to the class-A beta-lactamase family.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AF279904; AAG44836.1; -; Genomic_DNA.
DR RefSeq; WP_063857821.1; NG_048690.1.
DR AlphaFoldDB; Q9EZQ7; -.
DR SMR; Q9EZQ7; -.
DR SABIO-RK; Q9EZQ7; -.
DR GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR GO; GO:0008800; F:beta-lactamase activity; IEA:UniProtKB-EC.
DR GO; GO:0030655; P:beta-lactam antibiotic catabolic process; IEA:InterPro.
DR GO; GO:0046677; P:response to antibiotic; IEA:UniProtKB-KW.
DR Gene3D; 3.40.710.10; -; 1.
DR InterPro; IPR012338; Beta-lactam/transpept-like.
DR InterPro; IPR045155; Beta-lactam_cat.
DR InterPro; IPR000871; Beta-lactam_class-A.
DR InterPro; IPR023650; Beta-lactam_class-A_AS.
DR PANTHER; PTHR35333; PTHR35333; 1.
DR Pfam; PF13354; Beta-lactamase2; 1.
DR PRINTS; PR00118; BLACTAMASEA.
DR SUPFAM; SSF56601; SSF56601; 1.
DR PROSITE; PS00146; BETA_LACTAMASE_A; 1.
PE 1: Evidence at protein level;
KW Antibiotic resistance; Cell membrane; Hydrolase; Lipoprotein; Membrane;
KW Palmitate; Signal.
FT SIGNAL 1..31
FT /evidence="ECO:0000255"
FT CHAIN 32..310
FT /note="Beta-lactamase AST-1"
FT /id="PRO_0000313797"
FT ACT_SITE 91
FT /note="Acyl-ester intermediate"
FT /evidence="ECO:0000250|UniProtKB:P9WKD3"
FT ACT_SITE 187
FT /note="Proton acceptor"
FT /evidence="ECO:0000250|UniProtKB:P9WKD3"
FT BINDING 151
FT /ligand="substrate"
FT /evidence="ECO:0000250|UniProtKB:P9WKD3"
FT BINDING 255..257
FT /ligand="substrate"
FT /evidence="ECO:0000250"
FT SITE 94
FT /note="Increases nucleophilicity of active site Ser"
FT /evidence="ECO:0000250|UniProtKB:P9WKD3"
FT LIPID 32
FT /note="N-palmitoyl cysteine"
FT /evidence="ECO:0000255"
FT LIPID 32
FT /note="S-diacylglycerol cysteine"
FT /evidence="ECO:0000255"
SQ SEQUENCE 310 AA; 32476 MW; 53668F7DBFF1A6B3 CRC64;
MTFSALPFRR ADRRRLLAAA LAACALTLTA ACDSGTVTVP VTDSVTTSAV ADPRFAELET
TSGARLGVFA VDTGSGRTVA HRADERFPMA STFKGLACGA LLREHPLSTG YFDQVIHYSA
AELVEYSPVT ETRVETGMTV RELCDAAITV SDNTAGNQLL KLLGGPEGFT ASLRSLGDAT
SRLDRWETDL NTAIPGDERD TTTPAALAAD YRALVVGDVL GAPERDQLKA WLVANTTGAT
RIRAGLPADW TVGDKTGSPA YGSALDVAVA WPPGRAPIVI AVLSTKSEQD AEPDNALLAE
ATRVVVDALG